Improving the lives of people with acute, rare and chronic disorders.
Chiesi USA is the U.S. affiliate of Chiesi Farmaceutici, S.p.A, a global R&D-focused pharmaceutical company located in Parma, Italy. We are a specialty pharmaceutical company committed to the development and...
Chiesi USA was established in 2014 with the acquisition of Cornerstone Therapeutics Inc., as the culmination of a strong strategic alliance first formed in 2009. The organizations shared a focus on their people and a desire to address unmet medical needs in the specialty...
Mission & values
At Chiesi, our mission is to be recognized as a research-focused international group, developing and bringing innovative, value-added medical solutions to healthcare providers and their patients.
Our high performing entrepreneurial team will exhibit self-confidence and a spirit of...
Chiesi USA, Inc. (the “Company”) has a Comprehensive Compliance Program that reflects the Company’s commitment to compliance with the full range of laws, regulations and policies that govern pharmaceutical marketing and selling activities in the United States. The Company’s...
Sunshine Act Compliance
The Sunshine Act, or National Physician Payment Transparency Program (Open Payments), is a section of the Patient Protection and Affordable Care Act of 2010. This program requires manufacturers of pharmaceuticals, medical devices and biologics that participate in U.S. federal health care programs...
Chiesi USA: Elevating the experience of managing each patient’s condition.
Chiesi USA is committed to developing and commercializing products that meet the needs of healthcare providers and their patients. We deliver our products and associated services to improve the treatment of...
Research & Development
Chiesi USA is continually developing new therapies for life-threatening diseases and expanding indications for our existing products. We are currently active in the design and implementation of clinical trials to evaluate the efficacy and safety of the therapies in our pipeline. Our...
Clinical Trial Transparency
As European Federation of Pharmaceutical Industries and Associations (EFPIA) members, Chiesi Group companies are committed to clinical trial transparency. All Chiesi studies are recorded on www.clinicaltrials.gov.
Scientific Journal Publication
Chiesi is also...
At Chiesi USA, social responsibility is central to our mission statement. We greatly value the partnerships we’ve established with nationwide patient organizations and non-healthcare related community-based charities.
Our employees desire to give back to the communities where...
Expanded access programs
Chiesi USA, Inc. Expanded Access Programs
Expanded Access, sometimes referred to as compassionate use, may be an option for certain individuals with serious or life-threatening conditions or diseases who have no satisfactory or comparable alternative therapy to treat the disease or condition...
Join Our Team
Our employees come first.
Chiesi is committed to helping each and every team member develop professionally and contribute to our extraordinary goal of changing patients’ lives. We believe the team always accomplishes more than the individual and that the success of our company depends on...
It’s fun. Fast-paced. Challenging.
We’re professionals. Passionate and purposeful. Creative. Smart. Deeply engaged.
We’re team players. We believe in the individual’s contribution to the whole.
We’re respectful. Our doors are...
Chiesi USA is an equal opportunity employer committed to hiring a diverse work force at all levels of our business. Our environment encourages each individual to reach his or her full potential and drive outstanding results. All qualified applicants receive consideration for...
Our Pay and Benefits
Our competitive pay and benefits package includes:
Competitive Base Salary
Long-Term Disability Insurance
Performance Based Incentive Compensation
Tuition Assistance Program
401K Retirement Savings Plan (Pre-tax and ROTH)
Thank you for your interest in joining Chiesi USA, Inc. (“Chiesi”).
In addition to posting open positions on our website, Chiesi works with professional recruiters to help identify top talent to join the Chiesi team. Chiesi does not, nor do its recruiting partners on Chiesi’s...
Chiesi USA, Inc.175 Regency Woods Place, Suite 600, Cary, NC 27518
IF YOU NEED IMMEDIATE MEDICAL ASSISTANCE, PLEASE DIAL 911.
Please select the best contact method for your inquiry:
General Information (including an employee directory)...
Chiesi USA seeks to provide access to our therapies for all patients, especially for those most in need.
If you are experiencing financial hardship, you may be eligible to receive assistance from one of our Copay Assistance Programs. Alternative programs may be available for...
Building a foundation. Improving patient lives. Delivering results.
Chiesi USA, Inc. is always seeking new opportunities to drive future growth through strategic acquisitions of companies, existing marketed or registration-stage products and late-stage development products.
At Chiesi USA, we are committed to supporting U.S.-based educational efforts of the medical communities we serve. Our grant program funding focuses on the following areas:
Independent medical education
Healthcare-related charitable support
Scientific project support
You may anonymously report potential violations of Chiesi’s corporate compliance and ethics programs by calling the Company’s corporate governance hotline at 1 (800) 799-6158.
If you wish to report a complaint, you are invited to communicate with...
Have a question related to our medicines? A member of the Chiesi USA Medical Information team would be happy to help.
Request can be submitted to a Chiesi Medical Information team member by using the following form, or via the email address or phone number listed at the bottom of this...
By using this Site, you accept the practices surrounding the collection, use and sharing of information in the manner described in this Privacy Statement.This Privacy Statement is effective as of January 7, 2019.
The purpose of this Policy is to describe how Chiesi...
This project was edited and produced by Dynamic Mind.
Web Resource Unavailable
The server hosting this resource is temporarily down for maintenance. Please try again later.Maintenance date:
ARGATROBAN for Injection, 50 mg per 50 mL
BETHKIS® (Tobramycin Inhalation Solution)
CARDENE®IV (nicardipine hydrochloride) Premixed Injection
CLEVIPREX® (clevidipine) injectable emulsion
CUROSURF® (poractant alfa) Intratracheal Suspension
KENGREAL® (cangrelor) for injection
PERTZYE® (pancrelipase) Delayed-Release Capsules
RETAVASE® (reteplase) for injection
ZYFLO® (zileuton tablets)